McGovern Eavan, Louapre Céline, Cassereau Julien, Flamand-Roze Constance, Corsetti Elise, Jegatheesan Prasanthi, Bendetowicz David, Giron Camille, Dunoyer Margaux, Villain Nicolas, Renaud Marie-Christine, Sauleau Paul, Michel Laure, Vérin Marc, Worbe Yulia, Falissard Bruno, Roze Emmanuel
AP-HP, Hôpital Pitié-Salpêtrière, Département de Neurologie, Paris, France; Sorbonne Université, France; INSERM U1127, CNRS 7225, Institut du Cerveau, Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Département de Neurologie, Paris, France; Sorbonne Université, France; INSERM U1127, CNRS 7225, Institut du Cerveau, Paris, France.
J Neurol Sci. 2021 Feb 15;421:117320. doi: 10.1016/j.jns.2021.117320. Epub 2021 Jan 20.
Neurophobia is a chronic disease of medical students and junior doctors. Early detection is needed to facilitate prevention and management as this fear can negatively impact patient care.
We conducted a two-part mono-centric study at the faculty of Medicine, Sorbonne University, in Paris. Part one: a cross-sectional study to validate a newly constructed neurophobia scale, NeuroQ. Part two: a prospective longitudinal study to assess the impact of The Move on student neurophobia using NeuroQ. A population-based sample of second-year medical students of the 2019 and 2020 class of the Faculty of Medicine of Sorbonne University were invited to participate.
NeuroQ incorporates the main themes of the neurophobia definition and demonstrates uni-dimensionality. Three hundred and ninety-five medical students participated in the study (mean age was 20.0 years, SD: 2.1 years) assessing the effect of The Move teaching on neurophobia. Two hundred and eighty-eight (72.9%) students were female. After the Move teaching the mean NeuroQ score was significantly lower compared to the baseline NeuroQ score (mean [SD] variation, -1.1 [2.6], p < 0.001). There was a 22.3% relative reduction in the number of neurophobic students after The Move teaching.
Our results highlight the utility of NeuroQ in assessing (i) baseline neurophobia and (ii) the impact of pre-clinical educational interventions on neurophobia. Furthermore, we have shown the importance of pre-clinical educational interventions, such as The Move, in tackling neurophobia.
神经恐惧症是医学生和低年资医生的一种慢性疾病。由于这种恐惧会对患者护理产生负面影响，因此需要早期检测以促进预防和管理。
我们在巴黎索邦大学医学院进行了一项分为两部分的单中心研究。第一部分：一项横断面研究，以验证新构建的神经恐惧症量表NeuroQ。第二部分：一项前瞻性纵向研究，使用NeuroQ评估“行动”对学生神经恐惧症的影响。邀请了索邦大学医学院2019级和2020级二年级医学生的基于人群的样本参与研究。
NeuroQ纳入了神经恐惧症定义的主要主题，并显示出单维度性。395名医学生参与了评估“行动”教学对神经恐惧症影响的研究（平均年龄为20.0岁，标准差：2.1岁）。288名（72.9%）学生为女性。“行动”教学后，NeuroQ平均得分与基线NeuroQ得分相比显著降低（平均[标准差]变化，-1.1[2.6]，p<0.001）。“行动”教学后，神经恐惧症学生的数量相对减少了22.3%。
我们的结果突出了NeuroQ在评估（i）基线神经恐惧症和（ii）临床前教育干预对神经恐惧症影响方面的效用。此外，我们还表明了临床前教育干预，如“行动”，在应对神经恐惧症方面的重要性。
